Related Experiment Video

Updated: Aug 2, 2026

Laparoscopic Anterior Right Hepatectomy: A Single-Center Experience
09:51

Laparoscopic Anterior Right Hepatectomy: A Single-Center Experience

Published on: December 4, 2023

ERCP in Patients With Cirrhosis: "Risky Business" Or "Just Do it"?

Tilak Shah1,2, Elliot B Tapper3,4

  • 1Division of Gastroenterology, Hunter Holmes McGuire Veterans Affairs Medical Center, Richmond, VA, USA.

The American Journal of Gastroenterology
|October 14, 2018
PubMed

Insights

Acute-on-chronic-liver-failure (ACLF) is more common after ERCP in cirrhosis patients, especially if complications arise. However, ERCP benefits may outweigh risks when indicated.

Area of Science:

  • Gastroenterology and Hepatology
  • Interventional Endoscopy
  • Liver Disease Research

Background:

  • Acute-on-chronic-liver-failure (ACLF) is a severe complication in patients with decompensated cirrhosis.
  • The risk of ACLF following endoscopic retrograde cholangiopancreatography (ERCP) in cirrhosis patients requires careful evaluation.
  • Understanding procedural risks is crucial for managing patients with advanced liver disease.

Discussion:

  • Leal et al. observed a higher incidence of ACLF in cirrhosis patients undergoing ERCP compared to non-intervention controls.
  • ACLF risk was not significantly higher for ERCP than other non-ERCP interventions, but increased substantially with ERCP-related adverse events (AEs).
  • ACLF can stem from both the need for ERCP and its complications, highlighting a complex risk-benefit dynamic.

Key Insights:

  • ERCP is associated with an increased risk of ACLF in patients with cirrhosis.
  • ERCP-related adverse events significantly elevate the risk of developing ACLF.
  • The indication for ERCP in cirrhosis patients must be weighed against the potential risk of ACLF.

Outlook:

  • Further research should focus on mitigating ERCP-related AEs in cirrhosis patients to reduce ACLF incidence.
  • Developing predictive models for ACLF risk in patients undergoing ERCP could guide clinical decision-making.
  • Optimizing patient selection and procedural techniques may improve outcomes for cirrhosis patients requiring ERCP.

Related Concept Videos

Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Endoscopic Procedures V: ERCP01:26

Endoscopic Procedures V: ERCP

Endoscopic Retrograde Cholangiopancreatography (ERCP) is a diagnostic procedure that combines endoscopy and fluoroscopy to diagnose and treat conditions related to the bile ducts, pancreatic ducts, and gallbladder. This procedure is beneficial for identifying and addressing blockages, gallstones, strictures, and tumors within the biliary or pancreatic systems. ERCP is both diagnostic and therapeutic, offering the ability to visualize and treat identified problems in one session.
Patient...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...